<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03998904</url>
  </required_header>
  <id_info>
    <org_study_id>muscle preservation study</org_study_id>
    <nct_id>NCT03998904</nct_id>
  </id_info>
  <brief_title>Muscle Preservation Hamstring Graft for ACL Reconstruction</brief_title>
  <official_title>Muscle Preservation Hamstring Graft for ACL Reconstruction: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hanyang University Seoul Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hanyang University Seoul Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      -  Muscle derived stem cell is a better source of stem cells than a tendon tissue

        -  Preservation of muscle derived stem cell may enhance bone-tendon integration and
           ligamentization of ACL hamstring graft
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>SNQ value of MRI</measure>
    <time_frame>6 months</time_frame>
    <description>signal of ACL graft-signal of quadriceps tendon/singal of background</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Graft Healing</condition>
  <arm_group>
    <arm_group_label>Muscle preservation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Muscle preservation for hamsting graft</description>
  </arm_group>
  <arm_group>
    <arm_group_label>None preservation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>No muscle preservation for hamstring graft</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Muscle preservation</intervention_name>
    <description>Muscle preservation during graft preparation of hamstring graft</description>
    <arm_group_label>Muscle preservation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No muscle preservation</intervention_name>
    <description>No muscle preservation during graft preparation of hamstring graft</description>
    <arm_group_label>None preservation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Primary ACL reconstruction using autogenous hamstring graft

        Exclusion Criteria:

          -  Combined meniscal or ligament surgery

          -  Combined osteoarthritis (KL grade II or more)

          -  chondral injury more than grade 2

          -  Refuse to undergo MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>JIN KYU LEE, MD</last_name>
    <phone>820222908485</phone>
    <email>gaia-silver@hnamail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hanyang University Seoul Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JIN KYU LEE</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 25, 2019</study_first_submitted>
  <study_first_submitted_qc>June 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 26, 2019</study_first_posted>
  <last_update_submitted>June 25, 2019</last_update_submitted>
  <last_update_submitted_qc>June 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hanyang University Seoul Hospital</investigator_affiliation>
    <investigator_full_name>JIN KYU LEE</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>no planned for now</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

